Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Hepatocellular × pazopanib × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 22 Sarcoma 17 Neoplasms 8 Breast Neoplasms 8 Neoplasm Metastasis 7 Ovarian Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Hemangiosarcoma 5 Fallopian Tube Neoplasms 5 Lung Neoplasms 4 Liposarcoma 4 Leiomyosarcoma 4 Kidney Neoplasms 4 Urinary Bladder Neoplasms 3 Sarcoma, Synovial 3 Neurofibrosarcoma 3 Histiocytoma, Malignant Fibrous 3 Sarcoma, Alveolar Soft Part 2 Recurrence 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Neuroendocrine Tumors 2 Melanoma 2 Gliosarcoma 2 Glioblastoma 2 Fibrosarcoma 2 Clear-cell metastatic renal cell carcinoma 2 Chondrosarcoma, Extraskeletal Myxoid 2 Carcinoma, Ovarian Epithelial 2 Brain Neoplasms 2

Interventions

Sorafenib 49 pembrolizumab 20 Nivolumab 18 Bevacizumab 16 Radiosurgery 15 Doxorubicin 12 lenvatinib 8 Erlotinib Hydrochloride 7 atezolizumab 6 Ramucirumab 6 Magnetic Resonance Spectroscopy 6 Cisplatin 6 tremelimumab 5 durvalumab 5 cabozantinib 5 Radiofrequency Ablation 5 tislelizumab 4 Sunitinib 4 Ipilimumab 4 regorafenib 3 nintedanib 3 carotuximab 3 bavituximab 3 Ribavirin 3 Radiotherapy 3 Oxaliplatin 3 Mitomycin 3 Leucovorin 3 Fluorouracil 3 Everolimus 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡